These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 132666)

  • 41. Hyperglycemic effect of amino compounds structurally related to caproate in rats.
    Caster WO; Bleecker S
    J Nutr; 1975 Mar; 105(3):308-10. PubMed ID: 1117341
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of atorvastatin and pravastatin on glucose tolerance in diabetic rats mildly induced by streptozotocin.
    Kanda M; Satoh K; Ichihara K
    Biol Pharm Bull; 2003 Dec; 26(12):1681-4. PubMed ID: 14646170
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-hyperglycemic activity of natural and fermented Cordyceps sinensis in rats with diabetes induced by nicotinamide and streptozotocin.
    Lo HC; Hsu TH; Tu ST; Lin KC
    Am J Chin Med; 2006; 34(5):819-32. PubMed ID: 17080547
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Age-dependent changes in the sensitivity of the rat to a diabetogenic agent (streptozotocin).
    Masiello P; De Paoli A; Bergamini E
    Endocrinology; 1975 Mar; 96(3):787-9. PubMed ID: 123196
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Streptozotocin diabetes. Correlation with extent of depression of pancreatic islet nicotinamide adenine dinucleotide.
    Anderson T; Schein PS; McMenamin MG; Cooney DA
    J Clin Invest; 1974 Sep; 54(3):672-7. PubMed ID: 4369217
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low-dose streptozotocin induces sustained hyperglycemia in Macaca nemestrina.
    Gaur LK; Nepom GT; Lernmark A
    Autoimmunity; 2001; 33(2):103-14. PubMed ID: 11264789
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increase of opioid mu-receptor gene expression in streptozotocin-induced diabetic rats.
    Cheng JT; Liu IM; Chi TC; Tzeng TF
    Horm Metab Res; 2001 Aug; 33(8):467-71. PubMed ID: 11544560
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of streptozotocin-induced hyperglycemia on agonist-stimulated phosphatidylinositol turnover in rat aorta.
    Legan E
    Life Sci; 1989; 45(5):371-8. PubMed ID: 2528045
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Streptozotocin diabetogenic action in an experimental neonatal induction model.
    Bequer L; Gómez T; Molina JL; Artiles D; Bermúdez R; Clapés S
    Biomedica; 2016 Jun; 36(2):230-8. PubMed ID: 27622484
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Streptozotocin-induced hyperglycemia in rats: analysis of complement activity after streptozotocin administration.
    Perloff JR; Levy MM; Ketchum RJ; Read AD; White D; Brayman KL
    Transplant Proc; 1995 Dec; 27(6):3399. PubMed ID: 8540017
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects of compound K on hyperglycemia and insulin resistance in rats with type 2 diabetes mellitus.
    Jiang S; Ren D; Li J; Yuan G; Li H; Xu G; Han X; Du P; An L
    Fitoterapia; 2014 Jun; 95():58-64. PubMed ID: 24613802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-hyperglycemic activity of selenium nanoparticles in streptozotocin-induced diabetic rats.
    Al-Quraishy S; Dkhil MA; Abdel Moneim AE
    Int J Nanomedicine; 2015; 10():6741-56. PubMed ID: 26604749
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diazoxide modification of streptozotocin-induced diabetes in rats.
    Culbert S; Sharp R; Rogers M; Felts P; Burr IM
    Diabetes; 1974 Apr; 23(4):282-6. PubMed ID: 4274695
    [No Abstract]   [Full Text] [Related]  

  • 54. Ileal interposition improves glucose tolerance in low dose streptozotocin-treated diabetic and euglycemic rats.
    Strader AD; Clausen TR; Goodin SZ; Wendt D
    Obes Surg; 2009 Jan; 19(1):96-104. PubMed ID: 18989728
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biochanin A improves insulin sensitivity and controls hyperglycemia in type 2 diabetes.
    Oza MJ; Kulkarni YA
    Biomed Pharmacother; 2018 Nov; 107():1119-1127. PubMed ID: 30257324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diabetic characteristics and alveolar bone loss in streptozotocin- and streptozotocin-nicotinamide-treated rats with periodontitis.
    Kim JH; Lee DE; Choi SH; Cha JH; Bak EJ; Yoo YJ
    J Periodontal Res; 2014 Dec; 49(6):792-800. PubMed ID: 24490978
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diabetogenic activity of deoxy-2-(((ethylnitrosoamino) carbonyl)amino)-D-glucopyranose.
    Anderson T; McMenamin M; Schein PS
    Biochem Pharmacol; 1975 Mar; 24(6):746-7. PubMed ID: 164873
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of aluminum chloride on blood glucose level and lipid profile in normal, diabetic and treated diabetic rats.
    Chary RP; Eerike M; Konda VR; Arunachalam R; Yeddula VR; Meti V; Devi TS
    Indian J Pharmacol; 2017; 49(5):357-365. PubMed ID: 29515276
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The anti-hyperglycemic activity of the fruiting body of Cordyceps in diabetic rats induced by nicotinamide and streptozotocin.
    Lo HC; Tu ST; Lin KC; Lin SC
    Life Sci; 2004 Apr; 74(23):2897-908. PubMed ID: 15050427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Undiagnosed hyperglycemia in clozapine-treated patients with schizophrenia.
    Sernyak MJ; Gulanski B; Leslie DL; Rosenheck R
    J Clin Psychiatry; 2003 May; 64(5):605-8. PubMed ID: 12755666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.